Toxicity of sorafenib: clinical and molecular aspects

Author： Blanchet Benoit   Billemont Bertrand   Barete Stéphane   Garrigue Hélène   Cabanes Laure   Coriat Romain   Francès Camille   Knebelmann Bertrand   Goldwasser François  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.9, Iss.2, 2010-03, pp. : 275-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib

By  

Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. : 783-799

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: Skin toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Sorafenib: Skin toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1384, 2012-01 ,pp. : 53-53

Adis International

Access to resources Recommend Favorite

Sorafenib: a clinical and pharmacologic review

By Iyer Renuka   Fetterly Gerald   Lugade Amit   Thanavala Yasmin  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1943-1955

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity

By Breitkreutz Iris   Anderson Kenneth C  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 973-985

Informa Healthcare

Access to resources Recommend Favorite